| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
4 companies
Kauffman Michael is a Director at Karyopharm Therapeutics Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 10 sells.
Estimated insider holdings value: $7.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2018 | KPTI Karyopharm Therapeutics Inc. | Chief Executive Officer | Sale+OE | 400 | $11.14 | $4,454.52 | - | |
| Nov 7, 2018 | KPTI Karyopharm Therapeutics Inc. | Chief Executive Officer | Sale+OE | 12,500 | $11.65 | $145,592.50 | -1.7% | |
| Oct 18, 2018 | KPTI Karyopharm Therapeutics Inc. | Chief Executive Officer | Sale+OE | 10,000 | $12.63 | $126,304.00 | -1.9% | |
| Oct 8, 2018 | KPTI Karyopharm Therapeutics Inc. | Chief Executive Officer | Sale+OE | 12,500 | $15.75 | $196,832.35 | -0.9% | |
| Sep 28, 2018 | VSTM Verastem, Inc. | Director | Buy | 4,000 | $7.49 | $29,960.00 | New | |
| Sep 18, 2018 | KPTI Karyopharm Therapeutics Inc. | Chief Executive Officer | Sale+OE | 10,000 | $18.26 | $182,615.00 | -1.9% | |
| Sep 7, 2018 | KPTI Karyopharm Therapeutics Inc. | Chief Executive Officer | Sale+OE | 12,500 | $19.31 | $241,383.75 | -1.7% | |
| Aug 20, 2018 | KPTI Karyopharm Therapeutics Inc. | Chief Executive Officer | Sale+OE | 10,000 | $17.46 | $174,568.00 | -1.9% | |
| Aug 7, 2018 | KPTI Karyopharm Therapeutics Inc. | Chief Executive Officer | Sale+OE | 12,500 | $18.04 | $225,556.25 | -1.7% | |
| Jul 18, 2018 | KPTI Karyopharm Therapeutics Inc. | Chief Executive Officer | Sale+OE | 10,000 | $18.27 | $182,686.00 | -1.9% |